Dynavax +17% premarket on COVID-19 vaccine plan

Dynavax Technologies (NASDAQ:DVAX) is up 17% premarket after collaborating with the University of Queensland as part of a Coalition for Epidemic Preparedness initiative to develop a vaccine to prevent COVID-19.